Kinaxis (TSE:KXS) Stock Gets Price Target Increase from National Bank Financial

Kinaxis (TSE:KXS – Get Free Report) had its price target increased by equities researchers at National Bank Financial from C$210.00 to C$245.00 in a report issued on Monday, BayStreet reports. The firm presently has an “outperform” rating on the stock. National Bank Financial‘s price objective would suggest a potential upside of 17.53% from the stock’s current price.

Other equities analysts have also recently issued reports about the company. Royal Bank Of Canada set a C$210.00 price objective on Kinaxis and gave the stock an “outperform” rating in a report on Wednesday, August 26th. BMO Capital Markets upped their target price on Kinaxis from C$195.00 to C$200.00 and gave the company an “outperform” rating in a report on Friday, August 7th. RBC Dominion Securities set a C$210.00 price target on Kinaxis and gave the company an “outperform” rating in a research report on Friday, October 23rd. Finally, Stifel Nicolaus lifted their price target on Kinaxis from C$200.00 to C$225.00 and gave the stock a “buy” rating in a research note on Thursday, October 29th. Eight equities research analysts have rated the stock with a Buy rating. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of C$210.56.

Read Our Latest Report on KXS

Kinaxis Price Performance

Kinaxis stock traded up C$1.77 during mid-day trading on Monday, reaching C$208.46. The company had a trading volume of 44,608 shares, compared to its average volume of 126,235. The stock’s 50-day simple moving average is C$182.77 and its 200-day simple moving average is C$156.56. Kinaxis has a 1 year low of C$117.22 and a 1 year high of C$209.12. The company has a debt-to-equity ratio of 11.18, a current ratio of 1.81 and a quick ratio of 2.29. The company has a market capitalization of C$5.64 billion, a P/E ratio of 65.14, a P/E/G ratio of 3.60 and a beta of 0.43.

Kinaxis (TSE:KXS – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported C$1.72 EPS for the quarter. The business had revenue of C$228.16 million for the quarter. Kinaxis had a return on equity of 22.26% and a net margin of 14.33%. On average, equities analysts predict that Kinaxis will post 4.25 EPS for the current year.

Insiders Place Their Bets

In related news, insider Andrew William Robert Bell sold 3,000 shares of Kinaxis stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of C$179.48, for a total transaction of C$538,440.00. Following the completion of the transaction, the insider directly owned 1,455 shares in the company, valued at C$261,143.40. The trade was a 67.34% decrease in their position. Also, insider Vasile Gelu Ticala sold 961 shares of Kinaxis stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of C$177.68, for a total value of C$170,750.48. Following the transaction, the insider owned 596 shares of the company’s stock, valued at C$105,897.28. This represents a 61.72% decrease in their ownership of the stock. Over the last ninety days, insiders sold 33,730 shares of company stock valued at $5,877,368. Corporate insiders own 1.20% of the company’s stock.

Kinaxis Company Profile

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.